| ¡Avance histórico! Autoridades sanitarias de EE.UU. aprobaron una nueva inyec…
|💉 ¡Avance histórico! Autoridades sanitarias de EE.UU. aprobaron una nueva inyección que previene el VIH. El medicamento debe aplicarse cada seis me…
Washington D.C. – US health authorities have announced the approval of a revolutionary new injection, Lenacapavir, designed to prevent HIV transmission. This development marks a significant milestone in the fight against the global HIV epidemic. The new medication, which needs to be administered only twice a year, offers a promising alternative to daily pill regimens, potentially increasing adherence and effectiveness among at-risk populations. Clinical trials have demonstrated a near 100% efficacy rate in preventing the transmission of the virus. Experts in public health commend the approval, stating that this long-acting injectable could be a game-changer. "This significantly reduces the burden on individuals who previously had to take daily medication, offering a more discreet and convenient option for prevention," said one medical professional. While the drug's cost is reported to be over $14,000 per dose, its long-term impact on public health and the potential to curb new infections could outweigh the initial investment. Health organizations are now evaluating strategies for making this vital treatment accessible to those who need it most, aiming for a substantial reduction in new HIV cases worldwide.
|💉 ¡Avance histórico! Autoridades sanitarias de EE.UU. aprobaron una nueva inyección que previene el VIH. El medicamento debe aplicarse cada seis me…